“Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic”, Braz. J. Pharm. Sci., vol. 59, p. e21067, Apr. 2023, doi: 10.1590/s2175-97902023e21067.